Henning Weigt

Title: Henning Weigt: Innovator in Therapeutical Composition

Introduction

Henning Weigt is a notable inventor based in Hanover, DE. He has made significant contributions to the field of therapeutical compositions, particularly in the treatment of diseases using dendritic cells. His innovative approach combines various receptor agonists to enhance the efficacy of these treatments.

Latest Patents

Henning Weigt holds a patent for a therapeutical composition containing dendritic cells. The patent describes a method for preparing a therapeutical composition that involves treating dendritic cells with a combination of at least one interferon gamma receptor agonist and at least one toll-like receptor 2 and/or TLR 6 agonist. This method aims to utilize pretreated dendritic cells for the treatment of various diseases and disorders.

Career Highlights

Weigt is associated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he continues to advance his research and innovations. His work focuses on developing new methods and compositions that can significantly impact therapeutic practices.

Collaborations

Throughout his career, Henning Weigt has collaborated with esteemed colleagues such as Peter Muhlradt and Norbert Krug. These collaborations have fostered a productive environment for innovation and research in the field of therapeutics.

Conclusion

Henning Weigt's contributions to the field of therapeutical compositions highlight his role as an innovator in medical research. His patent on dendritic cell treatments showcases the potential for advancements in therapeutic applications.